Our case emphasizes that genotyping should be performed in severe COPD patients with bronchiectatic changes without radiologically evident emphysema, despite normal AAT levels, and that COPD patients presenting with recurrent infections should be referred to the immunology and allergy clinic to be evaluated for PID. This evidence concerns the gene SERPINA1 and infection.